KR20070011466A - 흡입기 장치 - Google Patents
흡입기 장치 Download PDFInfo
- Publication number
- KR20070011466A KR20070011466A KR1020067023534A KR20067023534A KR20070011466A KR 20070011466 A KR20070011466 A KR 20070011466A KR 1020067023534 A KR1020067023534 A KR 1020067023534A KR 20067023534 A KR20067023534 A KR 20067023534A KR 20070011466 A KR20070011466 A KR 20070011466A
- Authority
- KR
- South Korea
- Prior art keywords
- recess
- capsule
- inhaler
- mouthpiece
- inhaler device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002775 capsule Substances 0.000 claims abstract description 52
- 229940079593 drug Drugs 0.000 claims abstract description 29
- 239000003814 drug Substances 0.000 claims abstract description 29
- 230000000149 penetrating effect Effects 0.000 claims abstract description 14
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims description 6
- 208000006673 asthma Diseases 0.000 claims description 6
- 230000002685 pulmonary effect Effects 0.000 claims description 4
- 239000003570 air Substances 0.000 description 13
- 210000003811 finger Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 210000003813 thumb Anatomy 0.000 description 3
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940124630 bronchodilator Drugs 0.000 description 2
- 239000000168 bronchodilator agent Substances 0.000 description 2
- 210000005224 forefinger Anatomy 0.000 description 2
- 229920012128 methyl methacrylate acrylonitrile butadiene styrene Polymers 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229960002052 salbutamol Drugs 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 description 1
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 description 1
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 229950000210 beclometasone dipropionate Drugs 0.000 description 1
- 102000014974 beta2-adrenergic receptor activity proteins Human genes 0.000 description 1
- 108040006828 beta2-adrenergic receptor activity proteins Proteins 0.000 description 1
- 229960004436 budesonide Drugs 0.000 description 1
- BZDKYAZTCWRUDZ-UHFFFAOYSA-N buta-1,3-diene;methyl 2-methylprop-2-enoate;prop-2-enenitrile;styrene Chemical compound C=CC=C.C=CC#N.COC(=O)C(C)=C.C=CC1=CC=CC=C1 BZDKYAZTCWRUDZ-UHFFFAOYSA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229960000289 fluticasone propionate Drugs 0.000 description 1
- WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 description 1
- 229960002848 formoterol Drugs 0.000 description 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229960001361 ipratropium bromide Drugs 0.000 description 1
- KEWHKYJURDBRMN-ZEODDXGYSA-M ipratropium bromide hydrate Chemical compound O.[Br-].O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 KEWHKYJURDBRMN-ZEODDXGYSA-M 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229960002744 mometasone furoate Drugs 0.000 description 1
- WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 description 1
- 239000003149 muscarinic antagonist Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- NVOYVOBDTVTBDX-PMEUIYRNSA-N oxitropium Chemical compound CC[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1 NVOYVOBDTVTBDX-PMEUIYRNSA-N 0.000 description 1
- 229960000797 oxitropium Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002990 reinforced plastic Substances 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 229960004017 salmeterol Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical compound O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 description 1
- 229940110309 tiotropium Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
- A61M15/0025—Mouthpieces therefor with caps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0033—Details of the piercing or cutting means
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (10)
- 피흡입 분말형 약물을 담고 있는 캡슐을 보유하기 위한 리세스를 갖는 몸체와,리세스에 접선 방향으로 배치된 적어도 하나의 공기 통로와,몸체의 리세스와 연통하도록 되어 있는 동축으로 배치된 흡입 통로를 포함하는 마우스피스와,공기가 공기 통로를 통해 리세스 내로 들어가서 그 안에서 소용돌이칠 때 약물이 방출되도록 리세스에의 적재시에 캡슐을 관통하기 위한 상기 몸체 상의 캡슐 관통 수단을 포함하는 분말형 약물을 위한 흡입기 장치에 있어서,캡슐 관통 수단은 적어도 하나의 관통 요소를 각각 포함하는 한 쌍의 대향한 스프링 편향식 푸쉬 버튼을 포함하며, 마우스피스는 흡입기의 종방향 축에 수직인 축을 중심으로 개방 적재 위치와 폐쇄 분배 위치 사이를 피봇 운동할 수 있도록 몸체의 엣지에 피봇 가능하게 부착되는 것을 특징으로 하는 흡입기 장치.
- 제1항에 있어서, 관통 요소는 바늘 또는 뾰족한 핀인 흡입기 장치.
- 제1항 또는 제2항에 있어서, 리세스는 흡입기의 종방향 축을 중심으로 리세스 내에서 캡슐이 회전가능하도록 형성되는 흡입기 장치.
- 제1항 내지 제3항 중 어느 한 항에 있어서, 몸체는 몸체의 엣지에 마우스피스를 고정시키는 2이상의 연동 몸체부로 구성되는 흡입기 장치.
- 제1항 내지 제4항 중 어느 한 항에 있어서, 제거 가능한 캡을 포함하며, 마우스피스(30)와 결합하는 상기 캡의 내면에는 마우스피스 가이드가 제공되는 흡입기 장치.
- 제5항에 있어서, 리브는 흡입기의 몸체와 결합하는 캡의 입부에 인접한 캡의 내면에 구비되는 흡입기 장치.
- 제1항 내지 제6항 중 어느 한 항에 있어서, 분말형 약물을 담고 있는 캡슐을 포함하는 흡입기 장치.
- 제7항에 있어서, 약물은 폐흡입에 의해 천식이나 만성 폐색성 폐질환을 치료는데 적합한 흡입기 장치.
- 폐흡입에 의해 천식이나 만성 폐색성 폐질환을 치료하는데 적합한 약물을 투여하기 위해 제1항 내지 제8항 중 어느 한 항을 따른 흡입기 장치의 사용.
- 첨부딘 도면 중 하나 이상을 참조하여 명세서에 기재된 분말형 약물을 위한 흡입기 장치.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0410712.4 | 2004-05-13 | ||
GBGB0410712.4A GB0410712D0 (en) | 2004-05-13 | 2004-05-13 | Organic compounds |
PCT/EP2005/005182 WO2005113042A1 (en) | 2004-05-13 | 2005-05-12 | Inhaler device |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20070011466A true KR20070011466A (ko) | 2007-01-24 |
KR101170187B1 KR101170187B1 (ko) | 2012-07-31 |
Family
ID=32526997
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020067023534A Expired - Lifetime KR101170187B1 (ko) | 2004-05-13 | 2005-05-12 | 흡입기 장치 |
Country Status (31)
Country | Link |
---|---|
US (1) | US8479730B2 (ko) |
EP (1) | EP1747036B1 (ko) |
JP (2) | JP4914345B2 (ko) |
KR (1) | KR101170187B1 (ko) |
CN (1) | CN1953779B (ko) |
AR (1) | AR051353A1 (ko) |
AT (1) | ATE502666T1 (ko) |
AU (1) | AU2005245095B2 (ko) |
BR (1) | BRPI0511073B8 (ko) |
CA (1) | CA2563573C (ko) |
CY (1) | CY1111555T1 (ko) |
DE (1) | DE602005027064D1 (ko) |
DK (1) | DK1747036T3 (ko) |
EC (1) | ECSP066987A (ko) |
ES (1) | ES2362429T3 (ko) |
GB (1) | GB0410712D0 (ko) |
IL (1) | IL178878A (ko) |
MA (1) | MA28612B1 (ko) |
MX (1) | MXPA06013081A (ko) |
MY (1) | MY144563A (ko) |
NO (1) | NO334854B1 (ko) |
NZ (1) | NZ550625A (ko) |
PE (1) | PE20060098A1 (ko) |
PL (1) | PL1747036T3 (ko) |
PT (1) | PT1747036E (ko) |
RU (1) | RU2363501C2 (ko) |
SI (1) | SI1747036T1 (ko) |
TN (1) | TNSN06367A1 (ko) |
TW (1) | TWI353857B (ko) |
WO (1) | WO2005113042A1 (ko) |
ZA (1) | ZA200608728B (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200090802A (ko) * | 2017-11-23 | 2020-07-29 | 치아타이 티안큉 파마수티컬 그룹 주식회사 | 신형 드라이 파우더 흡입장치 |
KR20200144542A (ko) * | 2018-04-16 | 2020-12-29 | 엠파시스 임포르타도라 익스포르타도라 에 디스트리뷰이도라 엘티디에이. | 건조 분말 흡입기 |
Families Citing this family (109)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
SI1494732T1 (sl) | 2002-03-20 | 2008-08-31 | Mannking Corp | Inhalacijski aparat |
AU2005277208B2 (en) | 2004-08-20 | 2011-11-24 | Mannkind Corporation | Catalysis of diketopiperazine synthesis |
ES2540853T3 (es) | 2004-08-23 | 2015-07-14 | Mannkind Corporation | Sales de dicetopiperazina para la administración de fármacos |
WO2007033372A2 (en) | 2005-09-14 | 2007-03-22 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
AU2007216966C1 (en) | 2006-02-22 | 2014-03-20 | Mannkind Corporation | A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
CL2007001477S1 (es) * | 2006-11-27 | 2008-03-14 | Cipla Ltd | Camara de capsula. |
DE102007036411A1 (de) * | 2007-07-20 | 2009-02-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverinhalator |
EP2020249A1 (de) * | 2007-08-01 | 2009-02-04 | Boehringer Ingelheim Pharma GmbH & Co. KG | Inhalator |
PL2212323T3 (pl) | 2007-10-17 | 2013-01-31 | Novartis Ag | Pochodne imidazo[1,2-a]pirydyny użyteczne jako inhibitory ALK |
EP2534957B1 (en) | 2007-12-14 | 2015-05-27 | AeroDesigns, Inc | Delivering aerosolizable products |
US20090165783A1 (en) * | 2007-12-31 | 2009-07-02 | Mcdonald Molly | Nebulizer Apparatus and Method |
AU2009203693B2 (en) | 2008-01-11 | 2012-06-07 | Novartis Ag | Pyrimidines as kinase inhibitors |
ES2546025T3 (es) * | 2008-01-24 | 2015-09-17 | Vectura Delivery Devices Limited | Inhalador |
TR200803522A1 (tr) | 2008-05-16 | 2009-12-21 | Bi̇lgi̇ç Mahmut | Kolay kullanımlı inhalasyon cihazı. |
TR200803524A2 (tr) * | 2008-05-16 | 2009-12-21 | Bi̇lgi̇ç Mahmut | İnhalasyon cihazı. |
KR101629154B1 (ko) * | 2008-06-13 | 2016-06-21 | 맨카인드 코포레이션 | 건조 분말 흡입기 및 약물 투여 시스템 |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
BRPI0914308B8 (pt) | 2008-06-20 | 2021-06-22 | Mannkind Corp | sistema de inalação |
TWI614024B (zh) | 2008-08-11 | 2018-02-11 | 曼凱公司 | 超快起作用胰島素之用途 |
GB0818476D0 (en) * | 2008-10-09 | 2008-11-12 | Vectura Delivery Device Ltd | Inhaler |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
PL2405963T3 (pl) | 2009-03-11 | 2014-04-30 | Mannkind Corp | Urządzenie, układ i sposób pomiaru oporu inhalatora |
CA2758100C (en) | 2009-04-09 | 2017-08-29 | Novartis Ag | Process for preparing pyrrolidinium salts |
KR20190090092A (ko) | 2009-06-12 | 2019-07-31 | 맨카인드 코포레이션 | 한정된 비표면적을 갖는 디케토피페라진 마이크로입자 |
US9016147B2 (en) | 2009-11-03 | 2015-04-28 | Mannkind Corporation | Apparatus and method for simulating inhalation efforts |
WO2011110970A1 (en) | 2010-03-12 | 2011-09-15 | Ranbaxy Laboratories Limited | Single dose dry powder inhaler device |
JP6385673B2 (ja) | 2010-06-21 | 2018-09-05 | マンカインド コーポレイション | 乾燥粉末薬物送達システム |
US8372845B2 (en) | 2010-09-17 | 2013-02-12 | Novartis Ag | Pyrazine derivatives as enac blockers |
GB201020638D0 (en) * | 2010-12-06 | 2011-01-19 | Liconsa Laboratorios Sa | Inhalator |
CN102553040B (zh) * | 2010-12-17 | 2014-07-02 | 陈庆堂 | 滤出药粉吸入器 |
CN102553038B (zh) * | 2010-12-17 | 2014-07-02 | 陈庆堂 | 药粉吸嘴放置盒 |
JOP20120023B1 (ar) | 2011-02-04 | 2022-03-14 | Novartis Ag | صياغات مساحيق جافة من جسيمات تحتوي على واحد أو اثنين من المواد الفعالة لعلاج امراض ممرات الهواء الانسدادية او الالتهابية |
AU2012228300C1 (en) | 2011-03-15 | 2015-03-05 | Novartis Ag | Inhaler |
US8925726B2 (en) | 2011-04-01 | 2015-01-06 | Mannkind Corporation | Blister package for pharmaceutical cartridges |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
WO2013016784A1 (en) | 2011-08-04 | 2013-02-07 | Victor Esteve | Dry powder inhaler |
US8883819B2 (en) | 2011-09-01 | 2014-11-11 | Irm Llc | Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension |
HK1201475A1 (en) | 2011-10-24 | 2015-09-04 | Mannkind Corporation | Methods and compositions for treating pain |
BR112014014696A2 (pt) | 2011-12-23 | 2017-06-13 | Koninklijke Philips Nv | dispositivo para aplicação, sistema de aplicação, e mecanismo de aplicação |
EP2802584B1 (en) | 2012-01-13 | 2015-11-18 | Novartis AG | Salts of an ip receptor agonist |
US9326547B2 (en) | 2012-01-31 | 2016-05-03 | Altria Client Services Llc | Electronic vaping article |
US8809340B2 (en) | 2012-03-19 | 2014-08-19 | Novartis Ag | Crystalline form |
EP2666465A1 (en) | 2012-05-25 | 2013-11-27 | Almirall, S.A. | Novel dosage and formulation |
EP2668941A1 (en) | 2012-05-31 | 2013-12-04 | Almirall, S.A. | Novel dosage form and formulation of abediterol |
MX354163B (es) | 2012-07-12 | 2018-02-15 | Mannkind Corp | Sistemas y métodos de suministro de fármaco en polvo seco. |
US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
CN104968656B (zh) | 2012-12-19 | 2017-08-11 | 诺华股份有限公司 | 自分泌运动因子抑制剂 |
WO2014106727A1 (en) | 2013-01-03 | 2014-07-10 | Vectura Limited | Inhaler and formulation |
US9073921B2 (en) | 2013-03-01 | 2015-07-07 | Novartis Ag | Salt forms of bicyclic heterocyclic derivatives |
US9452139B2 (en) | 2013-03-14 | 2016-09-27 | Novartis Ag | Respirable agglomerates of porous carrier particles and micronized drug |
RU2698331C2 (ru) | 2013-03-14 | 2019-08-26 | Новартис Аг | Деаморфизация высушенных распылением составов посредством смешивания распылением |
CN105102436B (zh) | 2013-03-15 | 2018-06-12 | 曼金德公司 | 微晶二酮哌嗪组合物以及方法 |
WO2015006838A1 (en) | 2013-07-16 | 2015-01-22 | Victor Esteve | Powder inhaler |
AP2016009020A0 (en) | 2013-07-18 | 2016-02-29 | Novartis Ag | Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core |
WO2015010092A1 (en) | 2013-07-18 | 2015-01-22 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
EP3022201A1 (en) | 2013-07-18 | 2016-05-25 | Novartis AG | Autotaxin inhibitors |
CN105517607A (zh) | 2013-08-05 | 2016-04-20 | 曼金德公司 | 吹入设备和方法 |
JP5990866B2 (ja) * | 2013-10-11 | 2016-09-14 | 株式会社リーチハイアー | 経口粉末の吸入補助器具 |
WO2015091285A1 (en) | 2013-12-19 | 2015-06-25 | Almirall S.A. | Dosage formulation comprising salmeterol and fluticasone propionate |
AU2015237857B2 (en) | 2014-03-27 | 2017-08-10 | Novartis Ag | Spray-dried solid-in-oil-in-water dispersions for inhalation of active pharmaceutical ingredients |
WO2015148905A1 (en) | 2014-03-28 | 2015-10-01 | Mannkind Corporation | Use of ultrarapid acting insulin |
WO2015162558A1 (en) | 2014-04-24 | 2015-10-29 | Novartis Ag | Autotaxin inhibitors |
US10004732B2 (en) | 2014-04-24 | 2018-06-26 | Novartis Ag | Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors |
MX2016013981A (es) | 2014-04-24 | 2016-11-15 | Novartis Ag | Derivados de amino-piridina como inhibidores de fosfatidil-inositol-3-cinasa. |
AU2014391610B2 (en) | 2014-04-24 | 2018-01-25 | Novartis Ag | Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors |
PT107627B (pt) * | 2014-04-29 | 2017-03-08 | Hovione Farmaciência S A | Inalador de cápsulas com dobradiça |
WO2015173659A2 (en) | 2014-05-14 | 2015-11-19 | Novartis Ag | Carboxamide derivatives |
US20170088545A1 (en) | 2014-05-14 | 2017-03-30 | Novartis Ag | Carboxamide inhibitors |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
WO2016053525A1 (en) * | 2014-10-03 | 2016-04-07 | Illinois Tool Works Inc. | Reusable holder for a radioactive source capsule |
JP2018510668A (ja) * | 2015-01-12 | 2018-04-19 | ケダリオン セラピューティックス,インコーポレイテッド | 微小液滴の繰り出し装置及び方法 |
JP7040943B2 (ja) | 2015-01-20 | 2022-03-23 | ノバルティス アーゲー | 接続された物理装置を使用したアプリケーションのロック解除およびそれらの間のデータ転送 |
JP2018504964A (ja) | 2015-01-23 | 2018-02-22 | サンド・アクチエンゲゼルシヤフト | 流量プロファイルを生成するための装置および方法 |
EP3111978B1 (en) * | 2015-07-03 | 2021-09-01 | Novartis AG | Inhaler adapted to read information stored in a data storage means of a container |
US9877520B2 (en) * | 2015-07-29 | 2018-01-30 | Nitesh Rastogi | Hinged vaping system |
LT3347377T (lt) | 2015-09-09 | 2021-05-25 | Novartis Ag | Užkrūčio liaukos stromos limfopoetiną (tslp) rišantys antikūnai ir antikūnų panaudojimo būdai |
US20180303753A1 (en) | 2015-09-09 | 2018-10-25 | Keith Try Ung | Targeted delivery of spray-dried formulations to the lungs |
WO2017042701A1 (en) | 2015-09-09 | 2017-03-16 | Novartis Ag | Thymic stromal lymphopoietin (tslp)-binding antibodies and methods of using the antibodies |
USD867575S1 (en) * | 2015-11-19 | 2019-11-19 | Emphasys Importadora Exportadora e Distribuidora | Inhaler |
PT3199193T (pt) | 2016-01-28 | 2020-10-22 | Novartis Ag | Método para medir recursos de fluxo num inalador, inalador e sistema |
GB201605105D0 (en) | 2016-03-24 | 2016-05-11 | Nicoventures Holdings Ltd | Vapour provision apparatus |
GB201605100D0 (en) | 2016-03-24 | 2016-05-11 | Nicoventures Holdings Ltd | Vapour provision system |
MX2019005889A (es) * | 2016-11-30 | 2019-08-14 | Philip Morris Products Sa | Inhalador con tapon de extremo de remolinos. |
US11517686B2 (en) | 2016-12-20 | 2022-12-06 | Emphasys Importadora Exportadora E Distribuidora Ltda. | Dry powder inhaler |
KR20230107693A (ko) | 2017-01-20 | 2023-07-17 | 노파르티스 아게 | 압전 유체 분배기 |
FI3612262T3 (fi) * | 2017-04-18 | 2024-01-16 | Inspiring Pty Ltd | Kuivajauheinhalaattori ja kuivajauheinhalaattorin tilanjatkeväline |
ES2932836T3 (es) | 2017-07-25 | 2023-01-26 | Adherium Nz Ltd | Procedimiento y dispositivo de control de la adherencia |
CN107551368A (zh) * | 2017-10-12 | 2018-01-09 | 上海华瑞气雾剂有限公司 | 一种防划伤的干粉吸入器 |
AU2018380433B2 (en) | 2017-12-08 | 2024-10-10 | Bausch + Lomb Ireland Limited | Fluid delivery alignment system |
WO2019122361A1 (en) | 2017-12-22 | 2019-06-27 | Dr. August Wolff Gmbh & Co. Kg Arzneimittel | Asimadoline for use in treating pulmonary diseases, vascular diseases, and sepsis |
US11744960B2 (en) | 2017-12-28 | 2023-09-05 | Philip Morris Products S.A. | Inhaler with vortex tunnel |
US20190314198A1 (en) | 2018-04-12 | 2019-10-17 | Kedalion Therapeutics, Inc. | Topical Ocular Delivery Methods and Devices for Use in the Same |
US12350194B1 (en) | 2018-04-12 | 2025-07-08 | Bausch + Lomb Ireland Limited | Topical ocular delivery of fluids with controlled mass dosing and wireless communication |
AU2019297326B2 (en) | 2018-07-03 | 2025-01-09 | Bausch + Lomb Ireland Limited | Topical ocular delivery devices and methods for using the same |
CN109078245A (zh) * | 2018-10-11 | 2018-12-25 | 上海博极给药医药科技有限公司 | 一种双胶囊型干粉吸入装置 |
US12097145B2 (en) | 2019-03-06 | 2024-09-24 | Bausch + Lomb Ireland Limited | Vented multi-dose ocular fluid delivery system |
US20220296521A1 (en) | 2019-06-10 | 2022-09-22 | Respira Therapeutics, Inc. | Carrier-based formulations and related methods |
US11717621B2 (en) * | 2019-06-24 | 2023-08-08 | De Motu Cordis Pty Ltd | Automatic dispenser for respiratory delivery device |
US11793951B2 (en) * | 2019-06-24 | 2023-10-24 | De Motu Cordis Pty Ltd | Automatic dispenser for respiratory delivery device and method |
CN114945398A (zh) | 2019-12-09 | 2022-08-26 | 豪夫迈·罗氏有限公司 | 吸入器装置、与其一起使用的药物制剂以及制备方法 |
WO2021152119A1 (en) | 2020-01-31 | 2021-08-05 | Advita Lifescience Gmbh | Human anti-inflammatory peptides for the inhalatory treatment of inflammatory pulmonary diseases |
US12090087B2 (en) | 2020-04-17 | 2024-09-17 | Bausch + Lomb Ireland Limited | Hydrodynamically actuated preservative free dispensing system having a collapsible liquid reservoir |
EP4120974A4 (en) | 2020-04-17 | 2024-05-22 | Bausch + Lomb Ireland Limited | Hydrodynamically actuated preservative free dispensing system |
US12290472B2 (en) | 2020-04-17 | 2025-05-06 | Bausch + Lomb Ireland Limited | Hydrodynamically actuated preservative free dispensing system |
US11938057B2 (en) | 2020-04-17 | 2024-03-26 | Bausch + Lomb Ireland Limited | Hydrodynamically actuated preservative free dispensing system |
CN118750708A (zh) * | 2021-04-20 | 2024-10-11 | 苏州新劢德医疗器械科技有限公司 | 一种吸入装置 |
CN119255833A (zh) | 2022-05-24 | 2025-01-03 | 基因泰克公司 | 多单位剂量干粉吸入器及使用方法 |
US12171934B2 (en) * | 2023-05-23 | 2024-12-24 | De Motu Cordis Pty Ltd | Respiratory delivery device |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1016489B (it) | 1974-03-18 | 1977-05-30 | Isf Spa | Inalatore |
US3931671A (en) | 1974-09-30 | 1976-01-13 | Amp Incorporated | Terminal locator and retainer device |
EP0005585B1 (en) * | 1978-05-03 | 1981-08-12 | FISONS plc | Inhalation device |
GB8804069D0 (en) * | 1988-02-22 | 1988-03-23 | Britains Petite Ltd | Dispensers for powdered medication |
DE3927170A1 (de) * | 1989-08-17 | 1991-02-21 | Boehringer Ingelheim Kg | Inhalator |
NZ250988A (en) * | 1990-06-14 | 1995-09-26 | Rhone Poulenc Rorer Ltd | Powder inhaler: swirling chamber with anti-static walls |
US5797391A (en) * | 1991-03-28 | 1998-08-25 | Rhone-Poulenc Rorer Limited | Inhaler |
US5492112A (en) * | 1991-05-20 | 1996-02-20 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
RU2002467C1 (ru) * | 1991-06-25 | 1993-11-15 | Чучалин Александр Григорьевич; Бабарсков Евгений Викторович; Опенев В чеслав Иванович; Зезин Сергей Борисович; Коркина Людмила Георгиевна; Казначеев Владимир Александрович; Лох- мачев Александр Викторович | Ингал тор дл введени лекарственных средств в виде порошка |
JPH0611588U (ja) * | 1992-07-15 | 1994-02-15 | 富士通化成株式会社 | 表裏判別構造を有する耳かき |
AU119600S (en) | 1993-01-21 | 1994-03-07 | Boehringer Ingelheim Kg | Inhaler device |
IL108780A (en) * | 1993-02-27 | 1999-06-20 | Fisons Plc | Inhalation device |
DE4318455A1 (de) * | 1993-06-03 | 1994-12-08 | Boehringer Ingelheim Kg | Kapselhalterung |
SE9302550D0 (sv) * | 1993-07-30 | 1993-07-30 | Ernst Hoerlin | Powder inhaler |
US6209538B1 (en) * | 1995-08-02 | 2001-04-03 | Robert A. Casper | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament |
ES2172763T3 (es) * | 1996-02-21 | 2002-10-01 | Schering Corp | Inhalador de medicamento en polvo. |
JP3011898B2 (ja) * | 1997-02-20 | 2000-02-21 | フォルテ グロウ メディカル株式会社 | 吸引器 |
GB9913083D0 (en) | 1999-06-04 | 1999-08-04 | Novartis Ag | Organic compounds |
JP2001266903A (ja) * | 2000-03-21 | 2001-09-28 | Matsushita Electric Ind Co Ltd | 偏平型電池 |
GB0015876D0 (en) | 2000-06-28 | 2000-08-23 | Novartis Ag | Organic compounds |
ITMI20010357U1 (it) * | 2001-06-28 | 2002-12-30 | Plastiape Spa | Dispositivo inalatore |
GR1004350B (el) | 2002-03-29 | 2003-09-26 | Συσκευη εισπνοων ξηρης σκονης | |
PE20050130A1 (es) | 2002-08-09 | 2005-03-29 | Novartis Ag | Compuestos organicos |
AR044134A1 (es) | 2003-05-02 | 2005-08-24 | Novartis Ag | Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas. |
PE20050231A1 (es) | 2003-06-24 | 2005-05-20 | Novartis Ag | Derivados de piperidinium y pirrolidinium como antagonistas del receptor muscarinico m3 |
DE10352277A1 (de) * | 2003-11-08 | 2005-06-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverinhalator |
-
2004
- 2004-05-13 GB GBGB0410712.4A patent/GB0410712D0/en not_active Ceased
-
2005
- 2005-05-11 AR ARP050101913A patent/AR051353A1/es active IP Right Grant
- 2005-05-11 PE PE2005000523A patent/PE20060098A1/es active IP Right Grant
- 2005-05-12 AT AT05745323T patent/ATE502666T1/de active
- 2005-05-12 TW TW094115456A patent/TWI353857B/zh not_active IP Right Cessation
- 2005-05-12 WO PCT/EP2005/005182 patent/WO2005113042A1/en active Application Filing
- 2005-05-12 DE DE602005027064T patent/DE602005027064D1/de not_active Expired - Lifetime
- 2005-05-12 KR KR1020067023534A patent/KR101170187B1/ko not_active Expired - Lifetime
- 2005-05-12 PL PL05745323T patent/PL1747036T3/pl unknown
- 2005-05-12 JP JP2007512106A patent/JP4914345B2/ja not_active Expired - Lifetime
- 2005-05-12 NZ NZ550625A patent/NZ550625A/en not_active IP Right Cessation
- 2005-05-12 MX MXPA06013081A patent/MXPA06013081A/es active IP Right Grant
- 2005-05-12 US US11/568,466 patent/US8479730B2/en active Active
- 2005-05-12 SI SI200531319T patent/SI1747036T1/sl unknown
- 2005-05-12 ES ES05745323T patent/ES2362429T3/es not_active Expired - Lifetime
- 2005-05-12 CA CA2563573A patent/CA2563573C/en not_active Expired - Lifetime
- 2005-05-12 DK DK05745323.5T patent/DK1747036T3/da active
- 2005-05-12 AU AU2005245095A patent/AU2005245095B2/en not_active Expired
- 2005-05-12 CN CN2005800153538A patent/CN1953779B/zh not_active Expired - Lifetime
- 2005-05-12 RU RU2006143840/14A patent/RU2363501C2/ru active
- 2005-05-12 BR BRPI0511073A patent/BRPI0511073B8/pt active IP Right Grant
- 2005-05-12 PT PT05745323T patent/PT1747036E/pt unknown
- 2005-05-12 MY MYPI20052149A patent/MY144563A/en unknown
- 2005-05-12 EP EP05745323A patent/EP1747036B1/en not_active Expired - Lifetime
-
2006
- 2006-10-19 ZA ZA200608728A patent/ZA200608728B/xx unknown
- 2006-10-26 IL IL178878A patent/IL178878A/en active IP Right Grant
- 2006-11-10 TN TNP2006000367A patent/TNSN06367A1/en unknown
- 2006-11-10 EC EC2006006987A patent/ECSP066987A/es unknown
- 2006-11-29 MA MA29497A patent/MA28612B1/fr unknown
- 2006-12-12 NO NO20065718A patent/NO334854B1/no unknown
-
2011
- 2011-06-08 CY CY20111100552T patent/CY1111555T1/el unknown
- 2011-11-02 JP JP2011241398A patent/JP2012071146A/ja active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200090802A (ko) * | 2017-11-23 | 2020-07-29 | 치아타이 티안큉 파마수티컬 그룹 주식회사 | 신형 드라이 파우더 흡입장치 |
US11931506B2 (en) | 2017-11-23 | 2024-03-19 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Dry powder inhaler |
KR20200144542A (ko) * | 2018-04-16 | 2020-12-29 | 엠파시스 임포르타도라 익스포르타도라 에 디스트리뷰이도라 엘티디에이. | 건조 분말 흡입기 |
US12042599B2 (en) | 2018-04-16 | 2024-07-23 | Emphasys Importadora Exportadora E Distribuidora Ltda. | Dry powder inhaler |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101170187B1 (ko) | 흡입기 장치 | |
EP1381416B1 (en) | Inhalation device | |
RU2456026C2 (ru) | Усовершенствованный ингалятор для сухого порошкообразного препарата | |
RU2529691C2 (ru) | Ингалятор | |
EP1283731B1 (en) | Medicament dispensing system with a medicament container with same side airflow inlet and outlet | |
JP3790423B2 (ja) | 薬剤のデリバリの引き金となる吸入活性化流れ分割手段を有する乾燥粉末薬剤吸入器 | |
JP6683613B2 (ja) | 乾燥粉末吸入器 | |
AU2002255808A1 (en) | Inhalation device and method | |
JPS6155978B2 (ko) | ||
JPS636024B2 (ko) | ||
EP1485154B1 (en) | Powder inhalation device | |
HK1102919B (en) | Inhaler device | |
HK1061658B (en) | Inhalation device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0105 | International application |
Patent event date: 20061110 Patent event code: PA01051R01D Comment text: International Patent Application |
|
PG1501 | Laying open of application | ||
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20100223 Comment text: Request for Examination of Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20110829 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20120425 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20120725 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20120725 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20150630 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20160630 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20160630 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20170704 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20170704 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20180628 Year of fee payment: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20180628 Start annual number: 7 End annual number: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20200630 Start annual number: 9 End annual number: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20210629 Start annual number: 10 End annual number: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20220630 Start annual number: 11 End annual number: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20230628 Start annual number: 12 End annual number: 12 |
|
PR1001 | Payment of annual fee |
Payment date: 20240627 Start annual number: 13 End annual number: 13 |